Menu Search
Equities

Peijia Medical Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
4WO:MUN

Peijia Medical Ltd

Actions
  • Price (EUR)0.72
  • Today's Change-0.005 / -0.69%
  • Shares traded--
  • 1 Year change+58.59%
  • Beta1.2656
Data delayed at least 15 minutes, as of Feb 06 2026 07:01 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Peijia Medical Ltd is an investment holding company principally engaged in the provision of interventional procedural medical device. The Company primarily operates its businesses through two segments, Transcatheter Valve Therapeutic Business segment and Neurointerventional Business segment. Transcatheter Valve Therapeutic Business segment is mainly engaged in the business of research and development, manufacturing and sales of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is mainly involved in the business of research and development, manufacturing and sales of neurointerventional procedural medical devices. The Company’s products include commercialized products such as TaurusOne and TaurusElite. The Company mainly conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)751.41m
  • Net income in HKD-253.43m
  • Incorporated2012
  • Employees1.04k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.